Mechanism of Acute Respiratory Distress Syndrome (ARDS)

Phases of ARDS

Core Pathophysiology: Breakdown of the Alveolar-Capillary Barrier

Step-by-Step Mechanistic Cascade

1. Initiating Insult: Direct vs. Indirect Lung Injury

• Direct: pneumonia, aspiration of gastric contents, pulmonary contusion, toxic inhalation
• Indirect: sepsis (most common), major trauma, pancreatitis, massive transfusion (TRALI)

2. Innate Immune Activation

• TNF-α and IL-1β - amplify the inflammatory response
• IL-8 (CXCL8) and MIP-2 - potent neutrophil chemoattractants
• Platelet-activating factor (PAF) - promotes neutrophil-endothelial adhesion

3. Neutrophil Sequestration and Transmigration

• Pulmonary capillaries are narrower than the neutrophil diameter, so neutrophils must deform to pass through. Activated, "stiff" neutrophils (via actin cytoskeleton changes) cannot deform - they become sequestered in the microvasculature.
• One of the earliest signs of ARDS is a transient leukopenia from this pulmonary sequestration.
• Sequestered neutrophils then transmigrate across the endothelium into the interstitium and alveoli - this can occur without classical selectin/integrin-mediated adhesion once neutrophils are sequestered.
• Once in the alveolar space, activated neutrophils release a battery of injurious compounds:

4. Neutrophil Extracellular Traps (NETs)

• Direct endothelial damage
• Promotion of thrombosis within pulmonary capillaries
• Amplification of the local cytokine storm

5. Alveolar Epithelial Injury

• Alveolar flooding with protein-rich edema fluid
• Loss of surfactant function - phospholipase A2 (released from activated cells and pancreatic enzymes in pancreatitis) enzymatically degrades surfactant, promoting alveolar collapse and increased permeability
• Type II pneumocyte (ATII) dysfunction - normally responsible for surfactant synthesis and fluid clearance via Na⁺/K⁺-ATPase and ENaC (epithelial sodium channels). In ARDS, impaired ENaC and Na⁺/K⁺-ATPase activity leads to failure of alveolar fluid clearance, perpetuating the edema.
• ATII cells undergo death (apoptosis/necrosis), removing the progenitor pool for alveolar epithelial repair.

6. Endothelial Barrier Breakdown

• Loss of VE-cadherin and disruption of endothelial tight junctions
• Increased transcellular permeability via vesicle trafficking
• This allows protein-rich fluid, erythrocytes (free hemoglobin), and inflammatory cells to leak into the interstitium and alveolus

7. Coagulation Dysregulation

• Exposure of subendothelial tissue factor activates the extrinsic pathway
• Fibrin deposition within the alveolus contributes to hyaline membrane formation - the pathologic hallmark of DAD
• Monocyte-platelet aggregates and activated platelets amplify local thrombosis and release more inflammatory mediators
• Intravascular fibrin can compress pulmonary capillaries, contributing to pulmonary hypertension

8. Pulmonary Hypertension

• Hypoxic pulmonary vasoconstriction (HPV) in response to low alveolar PO2
• Intravascular fibrin deposition obstructing capillary flow
• Compression of blood vessels by positive-pressure mechanical ventilation
• Loss of capillaries from DAD in the fibrotic phase

9. Gas Exchange Failure

• Right-to-left shunt: consolidated, fluid-filled alveoli receive perfusion but no ventilation - shunted blood returns deoxygenated to the systemic circulation
• Severe hypoxemia refractory to supplemental O2 (the defining feature of ARDS)
• Increased dead space: ventilated alveoli without adequate perfusion (due to microvascular injury) raise minute ventilation requirements and are measurable as elevated dead-space fraction (a predictor of mortality)
• Decreased compliance from flooded, collapsed, and stiff alveoli

10. Amplifying Loops and Genetic Susceptibility

• MAPK pathway: p38 MAPK activation by LPS stimulates TNF-α production and MIP-2 release, driving further neutrophil chemotaxis. Inhibiting p38 MAPK even hours after LPS exposure attenuates lung injury in mice.
• PI3-kinase-γ in neutrophils mediates their chemotaxis toward IL-8 and bacterial peptides.
• Renin-angiotensin system: ACE converts angiotensin I to angiotensin II (vasoconstrictor); ACE2 counteracts this. Loss of ACE2 (e.g., downregulation by SARS-CoV-1/2 via spike protein binding) tips the balance toward vasoconstriction and injury. This is a mechanistic basis for severe COVID-19-associated ARDS.
• Genetic risk factors: DARC gene (African Americans), NF-kB gene (white patients), PPFIA1 (trauma patients), ANG2 variants (risk via elevated angiopoietin-2 levels), and ACE insertion/deletion polymorphism.

Summary Diagram

Triggering insult (sepsis, aspiration, trauma, etc.)
       ↓
TLR activation → NF-kB → cytokine storm (TNF-α, IL-1β, IL-8)
       ↓
Neutrophil sequestration in pulmonary microvasculature
       ↓
Transmigration → ROS, elastase, NETs, proteases
       ↓
Alveolar-capillary barrier disruption
       ↓
Endothelial permeability ↑ + Epithelial injury (ATI/ATII)
       ↓
Protein-rich edema floods alveoli + Surfactant inactivated
       ↓
Coagulation activated → fibrin deposition → hyaline membranes
       ↓
Alveolar collapse, right-to-left shunt, dead-space ↑
       ↓
Refractory hypoxemia (PaO2/FiO2 <300) = ARDS
       ↓ (if unresolved)
Fibroproliferation → pulmonary fibrosis

Sources

• Murray & Nadel's Textbook of Respiratory Medicine, Chapter 134 (Pathology, Neutrophils, Alveolar-Capillary Membrane, Genetic Determinants)
• Harrison's Principles of Internal Medicine, 22e (2025), Chapter 312 (Clinical Course and Pathophysiology)
• Goldman-Cecil Medicine, Chapter 90/91 (ARDS, Lung-Protective Ventilation)
• Sabiston Textbook of Surgery (Berlin Definition, Management Principles)